Transdermal Diagnostics, a MedTech venture spin-out from the University of Bath, is pioneering the development of bio-wearables with a primary focus on enhancing the prevention, diagnosis, and management of chronic conditions. Our revolutionary technology enables non-invasive, continuous co-monitoring of health biomarkers to catalyze a transformative shift in patient care and elevate overall quality of life.
Presently, we are in the process of creating the world's first 100% needle-free (and pain-free) CGM. This innovative device is designed to empower individuals living with diabetes, pre-diabetes, and obesity by providing them with personalized biological insights and enabling them to make informed decisions for a healthier lifestyle.
Company Details
- Employees
- 10
- Founded
- -
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
Transdermal Diagnostics Ltd Questions
Transdermal Diagnostics Ltd's website is https://www.transdermal-diagnostics.com
Transdermal Diagnostics Ltd's LinkedIn profile is https://www.linkedin.com/company/transdermal-diagnostics
Transdermal Diagnostics Ltd has
10 employees.
View email and phone details for 10
employees at Transdermal Diagnostics Ltd.
Transdermal Diagnostics Ltd's industry is
Medical Equipment Manufacturing
Transdermal Diagnostics Ltd's top competitors are
Scarlet Therapeutics Ltd,
Jam Up!,
Neuronostics,
Zentraxa,
Kasa Tech,
Transdermal Therapeutics,
Wild Hydrogen,
Epinal Ltd,
Staxy,
Ensilitech.
Transdermal Diagnostics Ltd's categories are Medical Equipment Manufacturing
Transdermal Diagnostics Ltd's founding year is 2021
